Rapid efficacy of efgartigimod for generalized myasthenia gravis patients in acute exacerbations/worsening: multicenter real-world retrospective study
Efgartigimod demonstrates rapid, significant efficacy in gMG acute exacerbations/worsening, supporting its role as a valuable therapeutic option for this high-risk population.
Authors
- Zhijun Li (ORCID: https://orcid.org/0009-0009-4250-3427)
- Bitao Bu (ORCID: https://orcid.org/0000-0001-5369-7751)
- Lianchen Xiao
- Yan Wu
- Jinquan Hu
- Jing Lin
- Chunsheng Yang
- Li Di
- Juanjuan Zhang
- Ting Chang
- Yan Jiang
Institutions
- University of Science and Technology of China (CN)
- Hubei University of Medicine (CN)
- Union Hospital (HK)
- Capital Medical University (CN)
- Anhui Medical University (CN)
- Tianjin Medical University General Hospital (CN)
- Hubei University of Arts and Science (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1007/s00415-026-13695-3
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 39.15
Funders
- National Science Foundation
- National Natural Science Foundation of China